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Abstract
Background: Modular polyketide synthases (PKSs) function as
molecular assembly lines in which polyketide chains are assembled
by successive addition of chain extension units. At the end of the
assembly line, there is usually a covalently linked type I
thioesterase domain (TE I), which is responsible for release of
the completed acyl chain from its covalent link to the synthase.
Additionally, some PKS clusters contain a second thioesterase
gene (TE II) for which there is no established role. Disruption of
the TE II genes from several PKS clusters has shown that the TE
II plays an important role in maintaining normal levels of
antibiotic production. It has been suggested that the TE II fulfils
this role by removing aberrant intermediates that might otherwise
block the PKS complex.
Results : We show that recombinant tylosin TE II behaves in
vitro as a TE towards a variety of N-acetylcysteamine and
p-nitrophenyl esters. The trends of hydrolytic activity determined
by the kinetic parameter kcat/KM for the analogues tested indicates
that simple fatty acyl chains are effective substrates. Analogues
that modelled aberrant forms of putative tylosin biosynthetic
intermediates were hydrolysed at low rates.
Conclusions: The behaviour of tylosin TE II in vitro is
consistent with its proposed role as an editing enzyme. Aberrant
decarboxylation of a malonate-derived moiety attached to an acyl
carrier protein (ACP) domain may generate an acetate, propionate
or butyrate residue on the ACP thiol. Our results suggest that
removal of such groups is a significant role of TE II. ß 2001
Elsevier Science Ltd. All rights reserved.
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1. Introduction
Polyketides, such as the macrolide antibiotics erythro-
mycin A and tylosin, constitute a large and structurally
diverse class of natural products that exhibit many impor-
tant biological activities. Their biosynthesis is achieved by
repeated condensations of simple carboxylic acid precur-
sors, activated as CoA thioesters, in a manner that closely
parallels fatty acid biosynthesis. Chain assembly takes
place on modular polyketide synthases (PKSs) that consist
of giant multifunctional proteins, with discrete catalytic
domains responsible for each successive cycle of chain
elongation. Many PKSs contain a terminal thioesterase
(TE) domain that is believed to catalyse the release of
the fully processed polyketide chain. Alternatively, a spe-
cialised cyclase or transferase may be used which forms an
amide bond, as in the pipecolate incorporating enzyme
thought to be associated with the rapamycin PKS [1], or
the amide synthetase found in the rifamycin PKS [2,3]. In
other PKS clusters, such as the type I iterative PKS re-
sponsible for 6-methylsalicylic acid biosynthesis [4] and the
dissociable type II iterative PKS responsible for actino-
rhodin biosynthesis [5], the mechanism of product release
remains a mystery.
Based on the synthase sequences published to date, the
type I TE (TE I) mechanism seems to be the preferred
method of release in type I systems. For example, the
domain sequence of the animal fatty acid synthase
(FAS) system terminates with a TE as shown in Fig. 1a,
as does the ¢nal module (module 6) of the modular type I
erythromycin PKS (also known as 6-deoxyerythronolide B
synthase or DEBS) shown in Fig. 1b. In the FAS, the
cycle of chain extension cycles is repeated iteratively until
a fatty acid chain of the required length is reached. At this
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point, the TE intervenes by recognising an intermediate of
the appropriate length, so that instead of being further
extended, the fatty acyl chain is released either by hydro-
lysis or by transfer to a suitable nucleophile. The TE of
the erythromycin PKS, in contrast, meets the growing
chain only after it has reached the appropriate stage of
development at the end of the synthetic operations in
module 6. The TE then ful¢ls its role by releasing the
polyketide chain as a macrolactone. In this context, the
TE I does not control chain length by substrate recogni-
tion and it has been shown to release intermediates at
various stages of chain extension when it is relocated to
earlier modules [6^9].
The mechanism of operation of the TE domains asso-
ciated with PKS and FAS enzymes is closely related to
that established for proteolytic enzymes such as chymo-
trypsin. In the ¢rst step, the full-length fatty acyl or
polyketide chain is transferred from the thiol group of
the phosphopantetheine arm of the acyl carrier protein
(ACP) onto the hydroxyl residue of a serine residue at
the active site of the TE. The resulting oxyester is then
cleaved in an ‘o¡-loading’ operation by a suitable nucleo-
philic species. This would be water in the case of hydro-
lysis, an external carbinol hydroxyl in the formation of an
ester, and a suitable distal hydroxyl group of the polyke-
tide chain in the formation of a lactone. The mode of
action of the TE I from the erythromycin PKS has been
established by in vitro experiments with a truncated ver-
sion of DEBS 3, comprising the ACP6-TE bidomain,
which was overexpressed in Escherichia coli [10^12]. In
these experiments, the substrate speci¢city of the TE I
was explored using various synthetic substrates [11,12].
The formation of an acyl^enzyme intermediate was dem-
onstrated for all substrates by electrospray ionisation-mass
spectrometry (ESI-MS) [10^12], consistent with the reac-
tion mechanism shown in Fig. 2. The very relaxed sub-
strate speci¢city of the TE I evident in these in vitro ex-
periments would not be a handicap in the context of the
Fig. 1. Chain release catalysed by TE domains in (a) FAS and (b) PKS systems.
Fig. 2. Mechanism of action of TEs to form an acyl^enzyme intermediate. The resultant tetrahedral intermediate is released by nucleophilic attack of
an external nucleophile or an internal nucleophile to form a lactone.
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DEBS system because the enzyme does not have to select
its substrate from the full set of intermediates on the syn-
thase.
The role of the integrated TE I domains at the carboxyl
termini of modular PKSs, therefore, has been clearly es-
tablished as one of acyl chain release. Furthermore, ex-
periments carried out both in vivo and in vitro have
shown that these TE Is are self-su⁄cient and do not re-
quire ancillary activities to carry out their normal function
[11^13]. Therefore, it is puzzling that many PKS clusters
contain additional TE genes (so-called type II TEs or TE
II) in the vicinity of the PKS genes, for which there is no
obvious role. So far, investigations into the putative roles
of TE IIs in polyketide biosynthesis have been based on
gene disruption strategies. Deletion of the TE II gene from
the pikromycin cluster of Streptomyces venezuelae led to a
mutant that produced less than 5% of the expected 12- and
14-membered macrolide products [14]. A similar result was
obtained with the tylosin producer Streptomyces fradiae,
where it was shown that only 10% of wild-type antibiotic
production was obtained when the tylosin TE II gene
(ORF5) was disrupted [15]. Deletion of the analogous
TE II gene, rifR, in the rifamycin PKS cluster of Amyco-
latopsis mediterranei also established that this additional
TE activity is required for normal accumulation of the
ansamycin antibiotic rifamycin B [16]. Together, these
studies suggest that TE IIs play a bene¢cial role during
polyketide biosynthesis, but are not essential for polyke-
tide production by modular PKSs.
To explain the outcome of their pikromycin TE II dis-
ruption experiments Xue et al. proposed that TE IIs may
behave as chain terminators and/or cyclases, allowing the
simultaneous production of polyketides of di¡erent chain
lengths [14], as is the case with TE IIs in FAS systems [17].
Experiments where the pikromycin PKS (PikAI^PikAIV)
was heterologously expressed in Streptomyces lividans,
however, have ruled out the possibility that the pikromy-
cin TE II domain is responsible for alternative chain ter-
mination, since both 12- and 14-membered ring products
accumulated [18]. Rather these experiments suggest that
the ability to produce polyketides of di¡erent chain
lengths is an inherent property of the pikromycin PKS
itself. A recent report in the literature has revealed the
presence of an alternative translational start site within
the pikAIV gene, which generates a truncated form of
pikromycin module 6 under certain growth conditions,
leading to the production of 10-deoxymethynolide [19].
Cundli¡e et al. have suggested that type II TEs play an
editing or corrective role during polyketide biosynthesis by
purging the PKS of abnormal polyketide intermediates
formed by the aberrant action of the biosynthetic machi-
nery of the PKS [15]. Schneider et al. have also speculated
that the free TE activity in peptide synthetase systems
might clear modules that are blocked by the presence of
Fig. 3. (a) A typical decarboxylative chain elongation step in FASs and PKSs. (b) Aberrant decarboxylation by the KS domain to give an acetate, pro-
pionate or butyrate residue attached to the ACP.
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aberrant intermediates [20]. Removal of the TE II in either
system could seriously delay the restoration of activity to
blocked modules, and ultimately could result in cessation
of polypeptide/polyketide biosynthesis in the absence of an
alternative clearance mechanism.
There are a number of possible ways in which the TE II
could carry out its editing activity during chain extension.
Firstly, it could behave as an indiscriminate chain release
enzyme, whereby any polyketide intermediate is removed
if it has a long enough half-life and is exposed to attack.
Alternatively, it could have the intrinsic ability to di¡er-
entiate between normal polyketide intermediates and those
containing mistakes and only remove incorrectly processed
polyketide chains.
Molecular mistakes might arise in a chain extension
module via a number of di¡erent mechanisms. Most ob-
viously, the chain elongation process in a given module
may take a wrong course, so that a keto group is reduced
to the wrong oxidation level or methyl/hydroxyl branching
groups with the wrong stereochemistry are produced. The
ACP of that module would then carry an aberrant prod-
uct, which could be cleared by further processing by
downstream domains to give an aberrant PKS product,
or by TE II, as will be explained.
In this paper, we propose an alternative mechanism for
generating aberrant acyl intermediates, in which mistakes
arise because of occasional malfunctioning of ketosynthase
(KS) domains. During normal chain extension, the acyl-
transferase (AT) domain transfers a chain extension unit
(e.g. methylmalonate) to the ACP. This is subsequently
bound to the KS active site (non-covalently), where it
normally undergoes concerted decarboxylative condensa-
tion with the acyl species attached to the KS active site
cysteine thiol (Fig. 3a). Occasionally, as an unwanted side
reaction, the KS may catalyse the decarboxylation of the
chain extender unit in the absence of a suitable acyl thio-
ester bound to the active site thiol of the KS. Protonation
of the resulting enolate would leave an acetate, propionate
or butyrate residue attached to the ACP (Fig. 3b). Here,
we describe in vitro experiments carried out with the TE II
from the tylosin-producing PKS of S. fradiae. By estab-
lishing a substrate speci¢city pro¢le for tylosin TE II, we
have gained valuable insights into the mechanism and
function of TE IIs in polyketide biosynthesis.
2. Results
2.1. Overexpression and puri¢cation of the tylosin TE II
The expression host of choice was E. coli, following the
successful overexpression of the ACP6-TE bidomain from
the carboxyl terminus of DEBS 3 [10] and the TE Is and
TE IIs associated with the rat FAS [21]. Following ampli-
¢cation of the ORF5 gene by polymerase chain reaction
(PCR) with mutagenic primers, designed to introduce an
NdeI restriction site spanning the ¢rst codon of the TE II
domain and a BamHI site at the 3P end of the gene, the
ORF5 gene was introduced into pUC18 and the accuracy
of ampli¢cation veri¢ed by DNA sequencing. The tylosin
TE II (ORF5) gene was subsequently cloned into the E. coli
expression plasmid pET-28b(+) to give pMLH27, so
that the TE II gene could be expressed as an N-terminal
His6-tagged protein. This plasmid was then used to trans-
form E. coli BL21(VDE3)pLysS. The total cell extracts
from induced and non-induced cells were analysed by so-
dium dodecyl sulphate^polyacrylamide gel electrophoresis
(SDS^PAGE). A band corresponding to 30 kDa (Fig. 4)
was detected in induced cells carrying the expression plas-
mid pMLH27, but was absent from induced cells carrying
the parent pET vector with no insert. The TE II protein
was puri¢ed to homogeneity by a⁄nity chromatography
using Ni-NTA super£ow resin (Qiagen), followed by an
anion exchange step (Fig. 4). Typically, 10 mg of protein
was obtained from 1 g of cells (wet weight).
2.2. Molecular weight determination for tylosin TE II
The recombinant tylosin TE II protein was analysed by
ESI-MS according to the methods used previously by
others for analysis of the rat mammary gland TE II [22]
and the ACP6-TE bidomain from the erythromycin PKS
in Saccharopolyspora erythraea [10,12]. The TE II mass
species from tylosin TE II produced a characteristic bell-
shaped distribution of multiply charged ions, with each
adjacent major peak in the spectrum di¡ering by one
charge. Spectra were subjected to a normal entropy trans-
form to give a single peak. Analysis of the puri¢ed tylosin
TE II protein by ESI-MS revealed a major species with a
molecular mass of 29 679.6 þ 1.3 Da. This corresponds to
the molecular mass predicted for the recombinant protein
Fig. 4. Puri¢cation of the heterologously expressed tylosin TE II do-
main. Samples of the recombinant protein were analysed by SDS^
PAGE at di¡erent stages of a typical puri¢cation procedure. Gels were
visualised by staining with Coomassie brilliant blue. Lane 1, molecular
weight markers; lane 2, soluble fraction from induced cells carrying
pMLH27; lane 3, Ni-NTA column £ow-through; lane 4, puri¢ed tylosin
TE II after a⁄nity chromatography; lane 5, molecular weight markers;
lane 6, puri¢ed tylosin TE II after anion exchange; lane 7, contaminant
proteins eluted after anion exchange.
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from which the N-terminal methionine has been removed
(Fig. 5).
The TE activity of various type I FASs is inhibited by
the well-characterised serine proteinase inhibitor phenyl-
methylsulphonyl £uoride (PMSF) [17,23]. Therefore puri-
¢ed tylosin TE II was treated with PMSF and analysed by
ESI-MS. The spectra revealed that about 30% of the re-
combinant protein had an increase in mass of 155 þ 2.0 Da
(data not shown), suggesting that a single reactive serine
residue was being speci¢cally modi¢ed. Complete modi¢-
cation of the TE II enzyme was not observed presumably
due to the occurrence of acid-catalysed elimination of the
PMSF group, a phenomenon that has been observed be-
fore with PMSF-treated ACP6-TE [10] and PMSF-treated
chymotrypsin [24].
2.3. Native molecular mass determination for tylosin TE II
The TE Is [25] and TE IIs [26] from the rat FAS are
monomeric, whereas the TE Is associated with modular
PKSs are dimeric [27,28]. The quaternary structure of
the recombinant tylosin TE II protein was investigated
using a combination of gel ¢ltration and analytical ultra-
centrifugation. The native molecular mass of the puri¢ed
tylosin TE II protein was estimated by gel ¢ltration chro-
matography on a calibrated Superdex 200 column. Tylosin
TE II eluted with an apparent molecular weight of 26 kDa
(calculated mass 30 kDa), suggesting that tylosin TE II
also exists as a monomer. This was con¢rmed by ultra-
centrifugation studies over a range of protein concentra-
tions and at di¡erent rotor speeds. The data for tylosin TE
II were ¢tted to various models, but the best ¢ts were
found with a model in which only the monomer was
present under any of the conditions used. This is in com-
plete contrast to the type I TE associated with the eryth-
romycin PKS [27].
2.4. Substrate speci¢city of tylosin TE II
TE-catalysed cleavage of an acyl thioester is believed to
involve two discrete steps which may have signi¢cantly
di¡erent structure speci¢city pro¢les, transfer of the acyl
chain from the thiol of the phosphopantetheine arm of the
ACP to the serine hydroxyl group in the active site of the
TE, and the subsequent cleavage of this intermediate acyl
ester by attack of a nucleophilic species (see Fig. 2). To
explore the acylation step, N-acetylcysteamine (NAC)
thioester derivatives are a logical choice, since they are
good structural mimics of the phosphopantetheine moiety
of the ACP. They therefore serve as close surrogates for
the natural ACP-bound acyl chain, which one might rea-
sonably surmise is the natural substrate for the TE II. For
demonstrating the formation of an acyl^enzyme intermedi-
ate and studying the deacylation step there is ample prece-
dent for preferring the more reactive p-nitrophenolate es-
ters [11,12]. p-Nitrophenyl esters are less appropriate
structural analogues of the ACP, but they are well-char-
acterised substrates for serine proteinases and have been
used routinely in studies on the TEs from animal FAS [29]
and the erythromycin PKS [11,12].
To investigate the substrate speci¢city of tylosin TE II,
puri¢ed enzyme was incubated with the NAC thioesters 1^
4 and p-nitrophenyl esters 5^8 of acetate, propionate, bu-
tyrate and pentanoate (Fig. 6a). The compounds 9 and 10
were also tested (Fig. 6b). These substrates were chosen to
represent incorrectly processed intermediates generated by
mistakes occurring during the chain elongation operations
of modules 1 and 2 of the tylosin PKS (intermediates 11
and 12, respectively, Fig. 6b).
The assay conditions used for monitoring the TE-cata-
lysed hydrolysis of the NAC thioesters 1^4 and 9 were
adapted from experiments reported by Tai et al. with the
rat TE II [30] and Gokhale et al. with the DEBS TE I
domain [28]. The release of free thiol was followed by
addition of Ellman’s reagent (5,5P-dithio-2-nitrobenzoic
acid, DTNB). DTNB reacts at neutral pH with sulfhydryl
groups to liberate the yellow compound 5-thio-2-nitroben-
zoic acid which can be monitored by UV spectroscopy
(Vmax = 412 nm, O= 13 600 M31 cm31). Each substrate
was tested at various concentrations by incubation with
tylosin TE II (1.3 WM) at 30‡C in assay bu¡er (200 mM
KPi (pH 7.5), 2.5 mM Tris^HCl (pH 7.5), 50 WM EDTA)
in the presence of DTNB (0.2 mM) and 3% (v/v) dime-
thylsulphoxide to aid substrate solubility. All assays were
carried out in duplicate, and the rate of reaction corrected
for the background rate of chemical hydrolysis in the ab-
sence of enzyme.
A plot of substrate turnover against the substrate con-
centration and the speci¢city constants (kcat/KM) for the
NAC thioesters 1^4 and 9 are shown in Fig. 7. It was not
practical to establish a substrate speci¢city pro¢le by com-
paring kcat and KM values, since they could only be esti-
mated for substrates 2 and 3. The remaining substrates
were not su⁄ciently soluble in the assay bu¡er to allow
kinetic measurements under substrate-saturating condi-
tions. Therefore comparisons between substrates were
made by calculation of the kcat/KM values at low substrate
Fig. 5. ESI-MS spectrum of the recombinant tylosin TE II protein. The
expected molecular mass of the enzyme from which the N-terminal me-
thionine has been removed is [M+H], 29 679.4 Da.
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Fig. 6. Substrates chosen for investigation of the speci¢city of tylosin TE II in vitro. (a) Substrates 1^8 were designed to test the e¡ect of chain length
on TE II speci¢city. (b) The ketide analogues 9 and 10 were modelled on the diketide 11 and triketide 12 biosynthetic intermediates of the tylosin PKS.
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concentration. All the NAC thioester substrates tested
were hydrolysed by tylosin TE II at a signi¢cant rate.
The trend in reactivity of each of the NAC thioesters, in
terms of the speci¢city constants, is in the order: propio-
nate 2s butyrate 3s acetate 1s pentanoate 4s diketide
9. These results indicate that tylosin TE II is capable of
removing simple fatty acyl chains produced by aberrant
decarboxylation of chain extender units. The fact that
there is a 14-fold di¡erence between the kcat/KM values
for propionate 2 and the diketide 9 suggests that the TE
II enzyme may play a signi¢cant but lesser role in remov-
ing incorrectly processed ketide intermediates.
In parallel studies, the p-nitrophenolate derivatives 5^8
and 10 were incubated with tylosin TE II (1.3 WM) at 30‡C
in assay bu¡er (200 mM KPi (pH 7.5), 2.5 mM Tris^HCl
(pH 7.5), 50 WM EDTA) in the presence of 3% (v/v) di-
methylsulphoxide to aid substrate solubility. The rate of
cleavage of the p-nitrophenyl esters 5^8 and 10 was moni-
tored at various substrate concentrations using UV spec-
troscopy, by following the rate of formation of the p-nitro-
phenolate anion (Vmax = 400 nm, O= 8570 M31 cm31). As
before, all assays were carried out in duplicate, and the
rate of reaction corrected for the background rate of
chemical hydrolysis in the absence of enzyme.
A plot of the initial rates of p-nitrophenol production
(i.e. substrate turnover) against the substrate concentra-
tion and the calculated values of kcat/KM for each sub-
strate are given in Fig. 8. Unfortunately, due to limits in
the solubility of the substrates 5^8 and 10 in the aqueous
assay bu¡er, substrate-saturating conditions were unat-
tainable and, therefore, the apparent KM and kcat values
for each substrate could not be calculated with any reli-
ability. As before, all substrates were hydrolysed at signi¢-
cant rates by the tylosin TE II. The high speci¢city con-
stants observed for the p-nitrophenyl esters 5^8 and 10
relative to the NAC thioesters 1^4 and 9 presumably re-
£ect the high reactivity of p-nitrophenol as a leaving
group. Comparison of the speci¢city constants for sub-
Fig. 7. Rate versus concentration plots for the hydrolysis of acyl NAC thioester substrates 1^4 and 9 by recombinant tylosin TE II. The kcat/KM values
for substrates 1, 4 and 9 were calculated from the linear slope of each plot at low substrate concentration, whereas the kcat/KM values for substrates for
substrates 2 and 3 were estimated using a Michaelis^Menten curve ¢t (Kaleidagraph software) or using an Eadie^Hofstee plot.
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strates 5^8 and 10 suggests that the substrate speci¢city of
the TE II enzyme is in the order: p-nitrophenyl propionate
6s p-nitrophenyl butyrate 7s p-nitrophenyl pentanoate
8s p-nitrophenyl acetate 5s triketide 10.
The di¡erent order of substrate speci¢city observed for
the p-nitrophenyl esters and the NAC thioesters (i.e. the
acetate (1, 5) and pentanoate esters (4, 8)) can be attrib-
uted to the fact that NAC thioesters are better structural
models of the natural acyl^ACP intermediate than p-nitro-
phenyl derivatives. p-Nitrophenyl esters are useful, how-
ever, since they have the potential to demonstrate the for-
mation of acyl^enzyme intermediates.
2.5. Studies of the acyl^enzyme intermediate
To con¢rm that the TE-catalysed hydrolysis reaction
progressed via an acyl^enzyme intermediate for all the
analogues tested, the reaction of tylosin TE II with sub-
strates 1^10 was followed by ESI-MS. Prior to ESI-MS
analysis, a solution of the substrate in acetonitrile (150
mM) was added to a solution of the enzyme in aqueous
bu¡er (50 mM Tris^HCl, pH 7.4; 1 mM EDTA) and
incubated at 30‡C for 5 min. The acylation reaction mix-
ture was subsequently diluted with a 1:1 solution of ace-
tonitrile/water, acidi¢ed with formic acid and analysed by
liquid chromatography-mass spectrometry (LC-MS).
These experiments were expected to reveal the extent of
acyl^enzyme formation and consequently whether acyla-
tion or deacylation is the rate-limiting step during TE-
catalysed cleavage of the NAC thioesters of poor sub-
strates. For activated esters like p-nitrophenyl derivatives,
deacylation of the acyl^enzyme intermediate is usually the
rate-determining step but, for more weakly activated esters
(e.g. NAC thioesters), acylation becomes at least partly
rate-determining. In the experiments with the NAC thio-
ester substrates 1^4 and 9, only small quantities of the
acyl^enzyme (6 5%) were formed at steady state. The sig-
nal to noise ratio was too high for con¢dent identi¢cation.
Fig. 8. Rate versus concentration plots for the hydrolysis of acyl p-nitrophenyl substrates 5^8 and 10 by recombinant tylosin TE II. The kcat/KM for
each substrate was calculated from the linear slope of each plot at low substrate concentration.
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Incubation of the p-nitrophenyl esters 5^8 and 10 with
tylosin TE II resulted in multiple acylation (up to 10-fold)
of the enzyme (see Fig. 9a for example). p-Nitrophenyl
esters are extremely reactive, so it seemed likely that
they were acylating other nucleophilic residues as well as
the active site serine. To ascertain the location of the addi-
tional acyl groups, the His6 tag was removed by thrombin
cleavage, and the resulting untagged protein re-incubated
with substrates 5^8. LC-MS analysis again showed the
presence of multiply acylated peaks (Fig. 9b). Inspection
of the peptide sequence of tylosin TE II revealed that there
were four cysteine residues present. These would be ideal
Fig. 9. Analysis of acylation experiments with tylosin TE II and p-nitrophenyl propionate 6 by ESI-MS. (a) Acylated tylosin TE II (with His6 tag).
(b) Acylated tylosin TE II (no His6 tag). (c) Tylosin TE II (no His6 tag)+DTNB in the absence of p-nitrophenyl propionate 6. (d) Acylated tylosin TE
II (no His6 tag)+DTNB.
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candidates for additional acylation sites because of the
nucleophilic character of the thiol group. Addition of the
thiol-modifying reagent DTNB to the untagged protein
gave a molecular species with an average molecular mass
of 28 717.0 Da, which is in excellent agreement with that
predicted for the enzyme with four modi¢ed cysteines.
Subsequent incubation of p-nitrophenyl propionate 6
with the DTNB-derivatised protein gave a peak corre-
sponding to a single acylation of the enzyme, suggesting
that the p-nitrophenyl ester substrates in the preliminary
studies had acylated four cysteine residues in addition to
the active site serine of the TE in the earlier experiments.
To ensure that these four cysteine residues did not in£u-
ence the observed turnover rate for the p-nitrophenyl es-
ters, hydrolytic assays were performed with tylosin TE II
(with and without a His6 tag) and the series of simple fatty
acyl p-nitrophenyl derivatives in the presence of 0.2 mM
DTNB. These assays con¢rmed that acylation of the cys-
teine residues and/or His6 tag did not a¡ect the overall
rate of hydrolysis of the p-nitrophenyl esters. These cys-
teine residues would, of course, be similarly derivatised by
the DTNB used in assaying the hydrolysis of the acyl
NAC thioesters.
3. Discussion
When considering the consequences of mistakes made
during polyketide biosynthesis, it is important to recognise
that modular PKSs are homodimeric and therefore that
chain extension modules occur in pairs. This is illustrated
in Fig. 10 with the two complementary polypeptide chains
arranged head-to-head and tail-to-tail. A combination of
complementation and cross-linking studies [27,31] has
shown that within a given complementary pair of modules,
the KS of one chain co-operates with the ACP in the
complementary chain. The growing polyketide chain
passes back and forth between one protein subunit as it
is passed down the synthase (see Fig. 10). A structural
model consistent with all the available data has the core
domains of each module twisted in a double helical array,
based on the tetrahedral arrangement of the KS and
AT domains. This allows the ACP domain in each module
to ¢t between the AT pair so that it is in close prox-
imity to its KS partner in the opposing chain. In this ar-
rangement, each KS can co-operate with only one of
the ACP domains in the homodimeric module. There-
fore, blockage of a particular ACP would be expected to
halve the rate of passage of intermediates through that
module and, hence, through the synthase as a whole. Con-
sequently, a low frequency of error over all the ACPs
would be su⁄cient to reduce the overall rate of polyketide
production to the serious extent observed in previous
studies.
To maintain the optimum rate of accumulation of poly-
ketide products the PKS requires a mechanism for remov-
ing aberrant structures from blocked ACPs. This could be
achieved without the intervention of an external agent if
the aberrant intermediate could be transferred to the KS
of the downstream module and further extended to pro-
duce a polyketide product with a mistake in its structure
due to the action of the malfunctioning module. However,
this mode of recovery might be relatively ine⁄cient with
the result that polyketide production is signi¢cantly re-
duced for an extended period. The TE II, where present,
o¡ers a more e⁄cient and immediate way of restoring
activity to blocked modules by purging the a¡ected ACP
domain directly of its aberrant substrate. This would in-
volve the direct interaction of the TE II with the incor-
rectly acylated ACP so that the acyl group is transferred
Fig. 10. A three-dimensional representation of a typical type I modular PKS multienzyme, based on the helical model. The complementary polypeptide
chains are coloured pink and blue, with the enzymatic domains shown as spheres. The arrows show the independent paths of the two growing polyke-
tide chains. In this arrangement, the KS of one polypeptide chain can only interact with the ACP of the opposing chain, as shown. If blockage of one
of the ACP domains occurs, the rate of passage of the polyketide chain through that module will be halved.
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to the active site serine of the TE II. The ACP would then
be free to resume its normal operations.
As a corrective agent in the context of a modular PKS,
the TE II may not necessarily require the inherent ability
to distinguish between normal polyketide intermediates
and those containing mistakes. In the normal operation
of a chain extension module, the correctly processed inter-
mediates will be strongly bound by the domains which are
responsible for their further elaboration and, therefore,
will be protected from the TE II, apart from a brief period
of exposure during transfer from one domain to the next.
An abnormal substrate, on the other hand, might not be
so tightly bound and consequently, may be more exposed
to attack. The TE II could, therefore, function e⁄ciently
by removing only projecting ketide chains from the PKS,
much as a hedge trimmer clips projecting shoots from an
untidy hedge.
In this paper, we propose that PKS modules may be-
come blocked by the presence of short fatty acyl thioesters
attached to the ACP, produced by aberrant decarboxyla-
tion of the malonate-derived residue intended for chain
extension in downstream chain extension modules. A
low rate of KS-catalysed non-condensative decarboxyla-
tion of methylmalonate moieties to give propionate can
be inferred from experiments with DEBS 1+TE and
DEBS 3, presumably due to the aberrant action of KS1
and KS5, respectively. Cell-free extracts containing DEBS
3 were shown to catalyse the synthesis of the expected
triketide lactone product by decarboxylation of an en-
zyme-bound methylmalonyl extender unit [32]. KS-cata-
lysed decarboxylation of methylmalonyl-CoA was also re-
ported to account for the biosynthesis of triketide lactone
in vitro by DEBS 1+TE in the absence of propionyl-CoA
[33], although it was subsequently shown that this can be
largely attributed to contamination of the commercial
methylmalonyl-CoA preparation with small quantities
(V5%) of propionyl-CoA [34]. Experiments carried out
by Katz et al. in vivo also suggest that initiation of chain
formation by the KS1-catalysed decarboxylation of meth-
ylmalonate moieties without carbon^carbon formation is
not a signi¢cant contributor to the £ux intermediates on
the erythromycin PKS [35]. Nevertheless, the occurrence
of an aberrant decarboxylation event at low frequency in
module 1 cannot be ruled out completely.
Further insight into the possible signi¢cance of KS-cat-
alysed decarboxylation has come from experiments with
FAS. Native yeast FAS has been shown to catalyse the
decarboxylation of malonyl-ACP [36], although only to a
very small extent (1^2% of total FAS activity). However,
when the active site cysteine is bound by either an acyl
group (as in the normal condensation reaction) or an alkyl
group (such as iodoacetamide), decarboxylation is stimu-
lated. In the case of iodoacetamide-treated FAS, the onset
of decarboxylation coincides with the abolition of fatty
acid synthesis. Similarly, the KSQ domains located in
the loading modules of modular PKSs (such as the tylosin
and monensin PKSs, for example) and the ‘CLF’ (KS-like)
subunits of aromatic PKSs catalyse the decarboxylation of
malonate moieties during the chain initiation process [37].
In both these KS-like domains, the active site cysteine is
replaced by a glutamine. Signi¢cantly, when the active site
cysteine of the FAS KS is treated with iodoacetamide, it is
converted into a carboxamidomethylcysteine residue,
which is very similar in size, shape and polarity to gluta-
mine. Normal KSs can also be converted into very e⁄cient
decarboxylases by replacement of the active site cysteine
with glutamine [37,38]. All these examples suggest that
there is a ¢ne balance between the operation of the normal
decarboxylative condensation reaction and decarboxyla-
tion without condensation. Therefore, it is reasonable to
suppose that a relatively low rate of aberrant decarboxy-
lation of malonate-derived units by KSs may be a wide-
spread property of modular PKSs. The necessary removal
of these unwanted acetyl, propionyl or butyryl groups
from the multienzyme complex could be the primary role
of the TE II.
The experiments described in this paper show that the
TE II of the tylosin cluster is catalytically competent as a
TE in vitro. It was able to catalyse the hydrolytic cleavage
of a range of NAC thioesters and p-nitrophenyl esters.
The NAC thioesters, in particular, were recognised as
good model substrates in a variety of systems for acyl
chains bound to the phosphopantetheine arm of the
ACP. It is signi¢cant that the best substrate analogues
for tylosin TE II with this form of derivatisation are the
short acyl chains acetate, propionate and butyrate, which
would be formed by aberrant decarboxylation of chain
extenders in the various chain extension modules of the
tylosin PKS. Representative polyketide chains are also
cleaved at a signi¢cant rate, indicating that tylosin TE II
could also remove aberrant intermediates arising from in-
correct operation of chain extension processes. However,
recent studies on the rifamycin PKS have demonstrated
that the analogous TE II RifR is not responsible for the
premature release of the various ketide intermediates
found in fermentations of A. mediterranei S699 wild-type
and rifF mutant strains [3,39].
It remains to be established whether the hypothetical
function deduced for tylosin TE II is applicable to all
TE IIs of PKS origin. Experiments with an ORF5-dis-
rupted strain of the tylosin producer S. fradiae suggest
that TE IIs associated with polyketide biosynthesis may
have a common function, as the equivalent TE II gene
nbmB from Streptomyces narbonensis was able to comple-
ment the ORF5 mutant and substantially restore polyke-
tide production [15].
4. Signi¢cance
High yield is crucially important in fermentation pro-
cesses to produce natural products. The earlier demonstra-
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tion that the TE II associated with the type I PKS respon-
sible for tylosin biosynthesis in S. fradiae helps to main-
tain high levels of macrolide production therefore deserved
investigation. Based on evidence that KSs can catalyse the
decarboxylation of malonate moieties to prime polyketide
biosynthesis on DEBS 3 or to initiate chain elongation in
the monensin and tylosin clusters (KSQ domain), we pro-
pose that occasionally, decarboxylation of chain extender
units in the absence of a suitable acyl group attached to
the KS thiol can occur as an unwanted side reaction, leav-
ing an unreactive acetate, propionate or butyrate residue
attached to the ACP. Such an aberrant decarboxylation
event, even at low levels, may be su⁄cient to severely
inhibit polyketide biosynthesis, unless the acyl group can
be removed. The experiments presented in this paper sug-
gest that tylosin TE II is an ideal candidate for an editing
enzyme, which functions by clearing the PKS of short
fatty acyl chains. In genetically engineered PKSs aberrant
decarboxylation may be more prevalent, therefore co-ex-
pression of a TE II may help to increase polyketide pro-
duction. A better understanding of this aspect of PKS
productivity could have signi¢cant bene¢ts for many com-
mercially important fermentation processes.
5. Materials and methods
5.1. Materials
Culture medium components were supplied by Difco. Reagents
for assays and for chemical synthesis were obtained from Aldrich
in the highest purity available and used without further puri¢ca-
tion. PMSF was obtained from Sigma. The NAC esters 1^4 were
prepared by reacting the appropriate acid chloride with NAC in
the presence of 4-dimethylaminopyridine. The unreacted NAC
present in the preparations was removed by elution from a silica
gel column impregnated with copper sulphate [40]. Syntheses of
the diketide 9 and triketide 10 have been reported previously [41].
5.2. Bacterial strains and plasmids
E. coli DH10B was used as the standard cloning host. Expres-
sion of proteins from T7-controlled pET vectors was performed
in E. coli BL21(VDE3)pLysS [42]. The T7-derived expression vec-
tor pET-28b(+) was obtained from Novagen.
5.3. Overexpression of the TE II domain
The tylosin ORF5 gene was overexpressed in E. coli as a His6-
tagged protein. Ampli¢cation of ORF5 by PCR under standard
conditions, was achieved using cosmid DNA containing the tyl-
BA region as a template, according to the method of Saiki et al.
[43]. The forward primer, [5P-d(GGCATATGTGGCTGCGTT-
GCTACGCCCCGGTCCCCGGCAC)-3P], was designed to intro-
duce an NdeI site overlapping the start codon, whereas the re-
verse primer, [3P-d(GGGGATCCTCAGTGAGCACTTTTGCT-
CCCATGGCGGAGT)-3P], was designed to introduce a BamHI
site downstream of the stop codon (restriction sites shown in bold
type). The PCR product was cloned into pUC18, digested with
NdeI and BamHI and subsequently cloned into the NdeI and
BamHI sites of the expression vector pET-28b(+). The resultant
plasmid pMLH27 was used to transform E. coli BL21(VDE3)-
pLysS for expression of the TE II gene. One liter cultures of
E. coli BL21(VDE3)pLysS/pMLH27 were grown in 2 l £asks us-
ing LB medium containing kanamycin (30 Wg ml31) and chlor-
amphenicol (34 Wg ml31) at 28‡C. Protein expression was induced
at A600 = 0.6 by addition of isopropyl thio-L-D-galactoside to a
¢nal concentration of 1 mM. Cells were harvested after 3 h by
centrifugation at 12 000Ug.
5.4. Puri¢cation of the TE II domain
All puri¢cation procedures were carried out at 4‡C. Induced
cells (5 g wet weight) were resuspended in 20 ml 50 mM phos-
phate bu¡er (pH 8.0) containing 300 mM NaCl, 10 mM imida-
zole, benzamidine/HCl, soybean trypsin inhibitor, DNase (5 Wg
ml31) and RNase (10 Wg ml31). The cells were broken by one
pass through a French press at 16 000 psi and insoluble material
was sedimented from the lysate by centrifugation at 40 000Ug for
30 min at 4‡C. The lysate was then mixed with previously equil-
ibrated Ni-NTA super£ow resin, allowed to bind for 1 h, then
packed into a column for the washing and elution steps. The
column was washed with 50 mM phosphate bu¡er (pH 8.0) con-
taining 300 mM NaCl, 20 mM imidazole, and the TE II eluted
with the same bu¡er containing 250 mM imidazole. Elution of
the proteins was monitored by recording the absorbance of the
eluate at 280 nm. Peak fractions were analysed by SDS^PAGE.
The fractions containing the recombinant protein were pooled
and desalted using a Hi-Trap desalting column (Pharmacia)
into 50 mM Tris^HCl (pH 7.4) containing 1 mM EDTA. The
sample was then applied to a Hi-Trap Q anion exchange column
(Pharmacia) at a £ow rate of 1 ml min31. Under these conditions,
tylosin TE II was found in the column £ow-through, whilst the
contaminant proteins bound to the column. Typically, 10 mg
puri¢ed protein was obtained from 1 g wet cells.
5.5. Treatment of puri¢ed protein with PMSF
Stock solutions of 100 mM PMSF in dimethyl formamide were
used. The puri¢ed protein, typically 0.8^1 mg ml31 in 5 mM
Tris^HCl (pH 7.4) containing 1 mM EDTA, was incubated at
0‡C for 1 h in the presence of 1 mM PMSF. Control protein
samples were treated with an equivalent volume of dimethyl
formamide.
5.6. ESI-MS of tylosin TE II
The methods used for ESI-MS were based on those used pre-
viously for analysis of the TE I domain of the erythromycin PKS.
A Liquid Chromatography-Quattro mass spectrometer (Micro-
mass, UK) was used, consisting of an electrostatic spray ion
source operating at atmospheric pressure, attached to a triple
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quadrupole mass analyser. Protein samples in 5 mM Tris^HCl
(pH 7.4), 1 mM EDTA were mixed with an equal volume of
acetonitrile and 0.1 vol of formic acid and introduced into the
ion source at a £ow rate of 4 Wl min31 (the mobile phase was
50:50 acetonitrile :water). Spectra were scanned from m/z 600 to
m/z 1500 at 10 s/scan, and processed using the Mass Lynx NT
data system. The mass scale was calibrated with horse heart my-
oglobin (average molecular mass 16 951.5 Da.
5.7. Determination of the kinetic parameters for TE-catalysed
hydrolysis
Hydrolysis of the NAC thioesters 1^4 and 9 was followed
spectrophotometrically by observation of the formation of
3-thio-5-nitrobenzoate at (Vmax = 412 nm, O= 13 600 M31 cm31).
Each assay contained (in a total of 1 ml) 200 mM potassium
phosphate (pH 7.4), 1.3 WM tylosin TE II, 10 Wl of a 20 mM
solution of DTNB in 200 mM potassium phosphate (pH 7.4) and
a variable amount of substrate dissolved in DMSO. Stock solu-
tions of 1^3 were 2 M in DMSO, whereas stock solutions of
4 and 9 were 1 M in DMSO. In all cases, the total content of
DMSO in the reaction was adjusted to 30 Wl. Reactions were
carried out in duplicate and the rate of hydrolysis calculated
from the initial linear portion of the curves. In all cases, the rates
were corrected for the background rate of chemical hydrolysis in
the absence of enzyme. Hydrolysis rates were measured over the
concentration range 10^60 mM for substrates 1^3, and 5^30 mM
for 4 and 9.
Hydrolysis of the p-nitrophenyl derivatives 5^8 and 10 was
monitored by following the rate of formation of the p-nitrophe-
nolate anion (Vmax = 400 nm, O= 8570 M31 cm31) at 30‡C. Each
assay contained (in a total volume of 1 ml) 200 mM potassium
phosphate bu¡er (pH 7.4), 1.3 WM tylosin TE II, and a variable
concentration of substrate in DMSO. Stock solutions of 5^6 were
100 mM in DMSO, whereas stock solutions of 7^8 and 10 were
50 mM in DMSO. In all cases, the total content of DMSO in the
reaction was adjusted to 30 Wl. Reactions were carried out in
duplicate and the rate of hydrolysis calculated from the initial
linear portion of the curves. In all cases, the rates were corrected
for the background rate of chemical hydrolysis in the absence of
enzyme. Hydrolysis rates were measured over the concentration
range 0.1^2.0 mM.
5.8. Acylation of tylosin TE II
The substrate (1 Wl of 150 mM solution in acetonitrile) was
added to an aqueous solution of tylosin TE II (10 Wl of 1.0 mg
ml31 solution in 50 mM Tris^HCl, pH 7.4; 1 mM EDTA) and
incubated at 30‡C for 5 min. The reaction mixture was then
diluted with acetonitrile (20 Wl) and water (20 Wl) and acidi¢ed
with formic acid (1 Wl). The resulting solution was subjected to
LC-MS analysis (Finnigan MAT LCQ, UK) using a Vydac pro-
tein C4 column (250U4.60 mm; 300 Aî ). Elution was achieved at
1 ml min31 with a gradient of 30^40% solvent B for 10 min
followed by a gradient of 40^50% solvent B for 20 min. Solvent
A: milli-Q water plus 0.1% TFA; solvent B: acetonitrile plus
0.1% TFA. Spectra were processed using Finnigan BioWorks
version 1.0 software.
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